|
P-157 A phase II study of XELOX and Cetuximab (Erbitux) as first-line therapy in patients with KRAS wild-type metastatic colorectal cancer (FLEET2) |
|
|
|
Titel: |
P-157 A phase II study of XELOX and Cetuximab (Erbitux) as first-line therapy in patients with KRAS wild-type metastatic colorectal cancer (FLEET2) |
Auteur: |
Iwamoto, S. Hazama, S. Kin, H. Takemoto, H. Kobayashi, K. Takahashi, Y. Kobayashi, M. Maeda, H. Nagata, N. Oba, K. Sakamoto, J. Mishima, H. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 27 () nr. S2 pagina's ii46 |
Jaar: |
2016 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|